- Home
- OXLCO vs FBIOP Comparison
OXLCO vs FBIOP Comparison
Compare OXLCO & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXLCO
- FBIOP
- Stock Information
- Founded
- OXLCO N/A
- FBIOP N/A
- Country
- OXLCO United States
- FBIOP United States
- Employees
- OXLCO N/A
- FBIOP 186
- Industry
- OXLCO Investment Managers
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- OXLCO Finance
- FBIOP Health Care
- Exchange
- OXLCO Nasdaq
- FBIOP Nasdaq
- Market Cap
- OXLCO N/A
- FBIOP N/A
- IPO Year
- OXLCO N/A
- FBIOP N/A
- Fundamental
- Price
- OXLCO $22.75
- FBIOP $6.61
- Analyst Decision
- OXLCO
- FBIOP
- Analyst Count
- OXLCO 0
- FBIOP 0
- Target Price
- OXLCO N/A
- FBIOP N/A
- AVG Volume (30 Days)
- OXLCO N/A
- FBIOP N/A
- Earning Date
- OXLCO N/A
- FBIOP N/A
- Dividend Yield
- OXLCO N/A
- FBIOP N/A
- EPS Growth
- OXLCO N/A
- FBIOP N/A
- EPS
- OXLCO N/A
- FBIOP N/A
- Revenue
- OXLCO N/A
- FBIOP N/A
- Revenue This Year
- OXLCO N/A
- FBIOP N/A
- Revenue Next Year
- OXLCO N/A
- FBIOP N/A
- P/E Ratio
- OXLCO N/A
- FBIOP N/A
- Revenue Growth
- OXLCO N/A
- FBIOP N/A
- 52 Week Low
- OXLCO N/A
- FBIOP N/A
- 52 Week High
- OXLCO N/A
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- OXLCO 40.31
- FBIOP 54.46
- Support Level
- OXLCO $22.69
- FBIOP $6.32
- Resistance Level
- OXLCO $23.13
- FBIOP $7.10
- Average True Range (ATR)
- OXLCO 0.12
- FBIOP 0.67
- MACD
- OXLCO -0.03
- FBIOP -0.03
- Stochastic Oscillator
- OXLCO 11.82
- FBIOP 61.01
About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.